-
<![CDATA[Dr Mayer on Giredestrant's Success in Early Breast Cancer]]>
17 Dec 2025 01:06 GMT
… that while giredestrant outperformed both tamoxifen and aromatase inhibitors, the … in patients previously treated with tamoxifen.
Subgroup analyses further confirmed … III lidERA Breast Cancer trial. Presented at: 2025 San Antonio Breast Cancer Symposium; …
-
Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?
16 Dec 2025 16:23 GMT
… with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence … of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone …
-
<![CDATA[Imlunestrant With/Without Abemaciclib Maintains PFS, OS Benefit in ER+/HER2– Breast Cancer]]>
12 Dec 2025 23:12 GMT
… patients with ER+, HER2– advanced breast cancer previously treated with aromatase inhibitors … therapy of aromatase inhibitor or tamoxifen.
References
Jhaveri KL, Neven … participants with ER+, HER2– advanced breast cancer (EMBER-3). ClinicalTrials.gov. …
-
<![CDATA[Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer ]]>
12 Dec 2025 22:45 GMT
… -positive), HER2-negative advanced breast cancer, Inluriyo (Imlunestrant), alone or … , HER2-negative advanced breast cancer previously treated with aromatase … tamoxifen.
References
"Imlunestrant with or without abemaciclib in advanced breast cancer …
-
<![CDATA[Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer]]>
12 Dec 2025 21:41 GMT
… ER+, HER2-negative breast cancer have limited effective options … exemestane, fulvestrant, or tamoxifen) plus everolimus until … receptor–positive advanced breast cancer,” Rugo concluded.
References … HER2-negative advanced breast cancer previously treated with …
-
Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer
12 Dec 2025 17:16 GMT
… /Advanced Breast Cancer
Metastatic/advanced breast cancer (ABC) is … cases of breast cancer diagnosed in 2024. Breast cancer is … certain HR+, HER2- breast cancers in the adjuvant … combination with endocrine therapy (tamoxifen or an aromatase inhibitor …
-
UCLA-led trial finds new drug reduces recurrence risk in common type of breast cancer
12 Dec 2025 03:54 GMT
… with HR-positive, HER2-negative breast cancer. Patients were randomly assigned … patients with breast cancer.”
Many patients with this type of breast cancer undergo … surgery followed by long-term endocrine therapy such as tamoxifen …
-
Mitigating Risk of Premature Ovarian Insufficiency Using Adjunct Chinese Herbal Medicines: A Nested Patient-Control Study in Female Cancer Patients with Chemotherapy
16 Dec 2025 11:49 GMT
… than in males, involving breast cancer, thyroid cancer, melanoma, … Tamoxifen in breast cancer patients undergoing hormone therapy.31 Using a breast-cancer … female patients with breast cancer in Taiwan: analysis … 4T1 cell induced breast cancer model. J Tradit …
-
She has stage four cancer. Her husband is a federal worker. Will she survive the Trump administration?
16 Dec 2025 12:09 GMT
… spine. It was metastatic breast cancer.
“I had no warning …
She had stage one breast cancer in 2014, but was … lumpectomy, radiation, chemotherapy and tamoxifen, a hormonal therapy. Through … of stage four metastatic breast cancer.
Composite of two images …
-
Morgan alumna helps others fight breast cancer
23 Oct 2025 12:00 GMT
… important than ever.
Breast cancer treatment has improved significantly … and biological factors influence breast cancer risk, particularly in … and is now taking tamoxifen to lower the … bias.”
Advances in breast cancer research have revolutionized treatment …
About
© 1995-2025